surveillance Search Results


86
Routledge Ltd surveillance
Surveillance, supplied by Routledge Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/kehlenbach_emil_stefan__2022__behind_the_silicon_curtain_a_critical_theory_of_big_data-239-18-32?v=Routledge+Ltd
Average 86 stars, based on 1 article reviews
surveillance - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Merck & Co rotavirus strain surveillance
Rotavirus Strain Surveillance, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/med_rxiv__64898__2026__03__29__26349659-240-69-65?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
rotavirus strain surveillance - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Surveillance Data Inc immunosuppressive drug costs
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Immunosuppressive Drug Costs, supplied by Surveillance Data Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc02518430-231-46-63?v=Surveillance+Data+Inc
Average 90 stars, based on 1 article reviews
immunosuppressive drug costs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Regenstrief Institute Inc syndromic surveillance infrastructure
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Syndromic Surveillance Infrastructure, supplied by Regenstrief Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc01560724-34-31-15?v=Regenstrief+Institute+Inc
Average 90 stars, based on 1 article reviews
syndromic surveillance infrastructure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Siemens AG surveillance siteiq analytics
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Surveillance Siteiq Analytics, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/us09807568-86-37-44?v=Siemens+AG
Average 90 stars, based on 1 article reviews
surveillance siteiq analytics - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
National Reference Center for Legionella routine surveillance of ev infections
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Routine Surveillance Of Ev Infections, supplied by National Reference Center for Legionella, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc11328644-68-12-19?v=National+Reference+Center+for+Legionella
Average 90 stars, based on 1 article reviews
routine surveillance of ev infections - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
OpenEye Scientific Software Inc surveillance cameras openeye digital video security solutions
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Surveillance Cameras Openeye Digital Video Security Solutions, supplied by OpenEye Scientific Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/10__1139_slash_cjz___2016___0271-91-4-6?v=OpenEye+Scientific+Software+Inc
Average 90 stars, based on 1 article reviews
surveillance cameras openeye digital video security solutions - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
IQVIA Inc injury/health condition data
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Injury/Health Condition Data, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/10__1249_slash_jsr__0000000000000711-69-11-24?v=IQVIA+Inc
Average 90 stars, based on 1 article reviews
injury/health condition data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies health surveillance programme
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Health Surveillance Programme, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc04741023__12863_2016_341_MOESM2_ESM-75-11-16?v=Federation+of+European+Neuroscience+Societies
Average 90 stars, based on 1 article reviews
health surveillance programme - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare johns hopkins specialized center for research excellence in sex differences
One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model <t>immunosuppressive</t> regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.
Johns Hopkins Specialized Center For Research Excellence In Sex Differences, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc09445235-212-27-22?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
johns hopkins specialized center for research excellence in sex differences - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
JMIR Publications Inc jmir public health & surveillance
Top journals in which Indian COVID-19 research published frequently.
Jmir Public Health & Surveillance, supplied by JMIR Publications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/pmc07348603-24-2-8?v=JMIR+Publications+Inc
Average 90 stars, based on 1 article reviews
jmir public health & surveillance - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd global resistance surveillance program
Top journals in which Indian COVID-19 research published frequently.
Global Resistance Surveillance Program, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surveillance/10__1128_slash_mbio__02162___15-55-25-30?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
global resistance surveillance program - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model immunosuppressive regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.

Journal:

Article Title: Lifetime Cost-Effectiveness of Calcineurin Inhibitor Withdrawal After De Novo Renal Transplantation

doi: 10.1681/ASN.2007040495

Figure Lengend Snippet: One-way sensitivity analysis of changes in the incremental cost per QALY versus MMF+Tac+ST for increases and decreases in the mean serum creatinine concentrations for model immunosuppressive regimens. (A) Increase in mean serum creatinine concentration for SRL+ST and MMF+CsA+ST with a stable value for MMF+Tac+ST. (B) Decrease in mean serum creatinine concentration for MMF+Tac+ST with stable values for SRL+ST and MMF+CsA+ST. Figures show a threshold analysis of changes in cost-effectiveness as increases or decreases in mean serum creatinine levels occur. In A, changes in cost-effectiveness are shown as mean serum creatinine increases for patients treated with SRL+ST and MMF+CsA+ST, while mean serum creatinine is maintained at its baseline value for patients treated with MMF+Tac+ST. In B, changes in cost-effectiveness are shown as mean serum creatinine decreases for patients treated with MMF+Tac+ST, while mean serum creatinine is maintained at its baseline value for patients treated with SRL+ST and MMF+CsA+ST.

Article Snippet: Additional annual medical costs as a result of diabetes in renal transplant patients (inflated to 2005 US dollars using the medical component of the Consumer Price Index, or $14,966) were obtained from Woodward et al . 38 For examination of drug costs in a comparable setting, immunosuppressive drug costs were estimated from the daily allowable consumption, in milligrams, for each regimen from the Surveillance Data, Inc., data set of March 2005.

Techniques: Concentration Assay

Top journals in which Indian COVID-19 research published frequently.

Journal: Diabetes & Metabolic Syndrome

Article Title: Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database

doi: 10.1016/j.dsx.2020.07.007

Figure Lengend Snippet: Top journals in which Indian COVID-19 research published frequently.

Article Snippet: 12.→ , JMIR Public Health & Surveillance , JMIR Publications Inc , 02 , 2.25 , –.

Techniques: Infection, Control